GSDME and neoplasm: Accompanied by the decrease of tumor-infiltrating lymphocytes, GSDME depletion also contributed to accelerate the tumor growth under the treatment of ORFV, which was confirmed by the changes of endpoint tumor weight (Fig. 4k, l).